Agenda

23/06/2021

Pre-clinical activity of palbociclib as monotherapy and in combination with anti-HER2 antibodies in HER2-positive breast cancer

Vitual a les 14:00h

Us convidem al proper IMIM Seminar, que tindrà lloc el dimecres 23/06/2021 a les 14:00 h. El títol serà "Pre-clinical activity of palbociclib as monotherapy and in combination with anti-HER2 antibodies in HER2-positive breast cancer", a càrrec del Mengjuan Qin, investigadora predoctoral del Grup de recerca en teràpia molecular del càncer de l'IMIM.

___________________________________________________________________________

We invite you to the next IMIM Seminar, which will take place on Wednesday 23/06/2021 at 14:00 h. The title will be "Pre-clinical activity of palbociclib as monotherapy and in combination with anti-HER2 antibodies in HER2-positive breast cancer", by Mengjuan Qin, Predoctoral Researcher, Molecular cancer therapeutics research group, IMIM.

Poster

Link to access

Todos los actos